ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Durata Therapeutics, Inc. 

89 Headquarters Plaza North
Suite 306
Morristown  New Jersey  07960  U.S.A.
Phone: 646-871-6480 Fax: 973-993-4865


SEARCH JOBS


Industry
Biotechnology






 Company News
Durata Therapeutics, Inc.  (DRTX) To Report Second Quarter 2014 Financial Results On August 7, 2014 7/31/2014 10:40:48 AM
Durata Therapeutics, Inc.  (DRTX) Enters Into An Exclusive License And Supply Agreement With Angelini To Commercialize Dalbavancin In Certain European Territories, Russia And Turkey 7/30/2014 10:47:33 AM
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014 6:33:05 AM
Durata Therapeutics, Inc.  (DRTX) To Present At Upcoming Investor Conferences 6/17/2014 8:40:34 AM
The New England Journal of Medicine Publishes Data From Durata Therapeutics, Inc.  (DRTX)'s Discover Program 6/5/2014 9:09:16 AM
FDA Approves Durata Therapeutics, Inc.  (DRTX)'s Dalvance To Treat Skin Infections 5/23/2014 2:08:54 PM
Durata Therapeutics, Inc.  (DRTX) To Present At Upcoming Investor Conferences 5/9/2014 9:53:21 AM
Durata Therapeutics, Inc.  (DRTX) Reports First Quarter 2014 Financial Results 5/8/2014 9:31:52 AM
Durata Therapeutics, Inc.  (DRTX) To Present Six Dalbavancin Posters At The 24th Annual ECCMID Meeting 5/2/2014 9:30:47 AM
Durata Therapeutics, Inc.  (DRTX) To Announce First Quarter 2014 Financial Results On May 8, 2014 5/1/2014 9:04:24 AM
12345678